Steroid-induced osteoporosis in systemic lupus erythematosus

被引：22

作者：

Cunnane, G ^{[1
]}

Lane, NE ^{[1
]}

机构：

[1] Univ Calif San Francisco, Div Rheumatol, San Francisco, CA USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2000年 / 26卷 / 02期

关键词：

D O I：

10.1016/S0889-857X(05)70140-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The patient with SLE is at considerable risk of osteoporosis, because of the inflammatory disease itself, its consequences, and its treatments. Because of their extensive use, glucocorticoids are thought to be the most frequent cause of drug-related osteoporosis and may be responsible for much of the bone loss in lupus. This article focuses on the mechanisms of steroid-induced osteoporosis in SLE and outlines strategies for prevention and treatment.

引用

页码：311 / +

页数：21

共 119 条

[1]

Adachi JD, 1996, J RHEUMATOL, V23, P995

[2] Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis [J].

Adachi, JD ;

Bensen, WG ;

Brown, J ;

Hanley, D ;

Hodsman, A ;

Josse, R ;

Kendler, DL ;

Lentle, B ;

Olszynski, W ;

SteMarie, LG ;

Tenenhouse, A ;

Chines, AA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :382-387

[3] THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS WITH NANDROLONE DECANOATE [J].

ADAMI, S ;

FOSSALUZZA, V ;

ROSSINI, M ;

BERTOLDO, F ;

GATTI, D ;

ZAMBERLAN, N ;

LOCASCIO, V .

BONE AND MINERAL, 1991, 15 (01) :72-81

[4] EFFECTS OF HYDROCHLOROTHIAZIDE AND DIETARY-SODIUM RESTRICTION ON CALCIUM-METABOLISM IN CORTICOSTEROID TREATED PATIENTS [J].

ADAMS, JS ;

WAHL, TO ;

LUKERT, BP .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1981, 30 (03) :217-221

[5]

ADINOFF AD, 1997, NEW ENGL J MED, V337, P382

[6] Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone [J].

Agnusdei, D ;

Gennari, C ;

Bufalino, L .

OSTEOPOROSIS INTERNATIONAL, 1995, 5 (06) :462-466

[7]

ALBANESE CV, 1992, P 1 INT S OST MET BO, P83

[8] Treatment of glucocorticoid-induced growth suppression with growth hormone [J].

Allen, DB ;

Julius, JR ;

Breen, TJ ;

Attie, KM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (08) :2824-2829

[9]

*AM COLL RHEUM, 1996, ARTHRITIS RHEUM, V39, P1291

[10] SAFETY OF HORMONE REPLACEMENT THERAPY (HRT) IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) [J].

ARDEN, NK ;

LLOYD, ME ;

SPECTOR, TD ;

HUGHES, GRV .

LUPUS, 1994, 3 (01) :11-13

← 1 2 3 4 5 6 7 8 9 10 →